Correction
- PMID: 35967910
- PMCID: PMC9368819
- DOI: 10.1093/immadv/ltac018
Correction
Abstract
[This corrects the article DOI: 10.1093/immadv/ltaa002.][This corrects the article DOI: 10.1093/immadv/ltab010.][This corrects the article DOI: 10.1093/immadv/ltaa007.].
© The Author(s) 2022. Published by Oxford University Press on behalf of the British Society for Immunology.
Erratum for
-
A glutamine 'tug-of-war': targets to manipulate glutamine metabolism for cancer immunotherapy.Immunother Adv. 2021 Jun 1;1(1):ltab010. doi: 10.1093/immadv/ltab010. eCollection 2021 Jan. Immunother Adv. 2021. PMID: 34541580 Free PMC article. Review.
Similar articles
-
Correction to: Advancement of antigen-specific immunotherapy: knowledge transfer between allergy and autoimmunity.Immunother Adv. 2023 Jul 27;3(1):ltad004. doi: 10.1093/immadv/ltad004. eCollection 2023. Immunother Adv. 2023. PMID: 37521948 Free PMC article.
-
Correction to: TIM-3: a tumor-associated antigen beyond checkpoint inhibition?Immunother Adv. 2023 Oct 12;3(1):ltad018. doi: 10.1093/immadv/ltad018. eCollection 2023. Immunother Adv. 2023. PMID: 37841366 Free PMC article.
-
Correction to: Immunology of allergen immunotherapy.Immunother Adv. 2023 Oct 12;3(1):ltad017. doi: 10.1093/immadv/ltad017. eCollection 2023. Immunother Adv. 2023. PMID: 37841368 Free PMC article.
-
Correction to: Characterization of sabatolimab, a novel immunotherapy with immuno-myeloid activity directed against TIM-3 receptor.Immunother Adv. 2023 Feb 18;3(1):ltad002. doi: 10.1093/immadv/ltad002. eCollection 2023. Immunother Adv. 2023. PMID: 36819977 Free PMC article.
-
Correction to: Peripheral blood persistence and expansion of transferred non-genetically modified Natural Killer cells might not be necessary for clinical activity.Immunother Adv. 2023 Feb 18;3(1):ltad003. doi: 10.1093/immadv/ltad003. eCollection 2023. Immunother Adv. 2023. PMID: 36819976 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources